Transgene Tasly (Tianjin) BioPharmaceutical Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Transgene Tasly (Tianjin) BioPharmaceutical General Information
Description
Manufacturer of immunotherapeutic products. The company develops and commercializes biotechnology products, including monoclonal antibody for development in inflammation and cancer, oncolytic viral immunotherapy to treat solid tumors, HBV therapeutic vaccine, HCV therapeutic vaccine and a second generation oncolytic virus developed in cancer for the Chinese market.
Contact Information
Corporate Office
- Tianjin
- China
Corporate Office
- Tianjin
- China
Transgene Tasly (Tianjin) BioPharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Transgene Tasly (Tianjin) BioPharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Transgene Tasly (Tianjin) BioPharmaceutical FAQs
-
When was Transgene Tasly (Tianjin) BioPharmaceutical founded?
Transgene Tasly (Tianjin) BioPharmaceutical was founded in 2010.
-
Where is Transgene Tasly (Tianjin) BioPharmaceutical headquartered?
Transgene Tasly (Tianjin) BioPharmaceutical is headquartered in Tianjin, China.
-
What industry is Transgene Tasly (Tianjin) BioPharmaceutical in?
Transgene Tasly (Tianjin) BioPharmaceutical’s primary industry is Pharmaceuticals.
-
Is Transgene Tasly (Tianjin) BioPharmaceutical a private or public company?
Transgene Tasly (Tianjin) BioPharmaceutical is a Private company.
-
What is the current valuation of Transgene Tasly (Tianjin) BioPharmaceutical?
The current valuation of Transgene Tasly (Tianjin) BioPharmaceutical is .
-
What is Transgene Tasly (Tianjin) BioPharmaceutical’s current revenue?
The current revenue for Transgene Tasly (Tianjin) BioPharmaceutical is .
-
Who are Transgene Tasly (Tianjin) BioPharmaceutical’s investors?
Transgene has invested in Transgene Tasly (Tianjin) BioPharmaceutical.
-
When was Transgene Tasly (Tianjin) BioPharmaceutical acquired?
Transgene Tasly (Tianjin) BioPharmaceutical was acquired on 20-Aug-2018.
-
Who acquired Transgene Tasly (Tianjin) BioPharmaceutical?
Transgene Tasly (Tianjin) BioPharmaceutical was acquired by Tasly Holding Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process